TVRD Stock: Tvardi Therapeutics, Inc. Stock Price, Analysis & Insights
Get live tvrd stock price $6.69, comprehensive Tvardi Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time tvrd stock data and investment insights.
Company Overview
Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Their lead candidate, TTI-101, is currently in Phase 2 clinical trials for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC).
Company Information
- CEO
- Imran Alibhai
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 17
Contact Information
- Address
- 2450 Holcombe Blvd, Suite X
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 62.73M market capitalization
- Trading Volume: 6.25M shares traded today
- Price Range: 52-week range of $5.65 - $43.65
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. (TVRD) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 62.73M, the company represents a significant player in its market. The stock is currently trading at $6.69 with a negativedaily change of 83.92%.
The company's 17 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -2.97, beta of 0.24, and 52-week price range from $5.65 to $43.65when evaluating investment opportunities.
Why Invest in Tvardi Therapeutics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under Imran Alibhai
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.